Warnings and Precautions for Using Copanlisib

The following is detailed information about the warnings and precautions for using Copanlisib/Copanlisib (Copanlisib) to ensure that patients receive maximum benefit and minimize potential risks when receiving treatment.

Warning:

1.Allergic reactions: Copanliside/Kupanisi may cause allergic reactions, including rash, itching, shortness of breath, swelling, throat tightness, etc. If patients develop allergic symptoms, they should stop taking the medication immediately and seek emergency medical help. Patients need to inform their doctor in advance if they have an allergic reaction to copanliside/copanisib or its ingredients.

2.Hyperglycemia: Copanliside/Copanisib may cause hyperglycemia, especially for patients with diabetes, and blood glucose levels need to be monitored closely. Patients may need to adjust the dose of their diabetes medications or take other steps to manage high blood sugar.

3.Pulmonary toxicity: Copanliside/Copanisib may cause pulmonary toxicity during use, including pneumonia and interstitial lung disease. Patients should pay close attention to respiratory symptoms such as shortness of breath, cough, and chest pain. If these symptoms occur, your doctor should be informed immediately.

4.Liver function impairment: Copanliside/Copanisib may have adverse effects on the liver, leading to abnormal liver function. Doctors usually monitor patients' liver function parameters regularly to detect problems in a timely manner and take appropriate measures.

5.Risk of infection: Copanliside/Copanisib may cause leukopenia and increase the risk of infection. Patients need to avoid exposure to infection-risk environments and take prophylactic antibiotic treatment as recommended by their doctor.

Notes:

1.Physician’s monitoring: Patients need to receive regular medical monitoring during the use of copanliside/cupanisi, including blood cell count, liver function, kidney function, blood sugar level, etc. This helps doctors evaluate the effectiveness and side effects of treatment.

2.Dosage and treatment plan: Copanliside/Copanisib The dosage and treatment plan should be formulated by a professional physician based on the patient's specific condition and type of disease. Patients should never change their dosage or treatment regimen on their own.

3. Your doctor may need to adjust the dosage of other medications or choose alternative treatments.

4.Pregnant and breastfeeding women: Pregnant women should avoid using copanliside/copanisib because it may cause harm to the fetus. Breastfeeding women should stop breastfeeding because copanliside/copanisib may be secreted into breast milk and have adverse effects on the baby.

5.Dose for special groups: Copanliside/Copanisib may require dose adjustment in special groups such as elderly patients and patients with impaired renal function. Patients need to discuss their specific situation with their doctor to determine the most appropriate treatment option.

6.Follow medical advice: Patients must strictly follow the doctor's recommendations and prescriptions and cannot change the treatment plan on their own. If you have any concerns or discomfort, you should contact the medical team promptly.

In summary, using copanliside/copanisib as an anticancer treatment requires close collaboration between patient and physician. Patients need to closely follow their doctor's recommendations and receive regular medical monitoring to ensure the success and safety of treatment. It is important for patients to understand warnings and precautions to help them better manage the risks and discomforts of treatment.

Copanliside/Kupanisi has just been launched in China and has not been included in medical insurance. The specific price may not be determined yet. Please consult your local pharmacy for details. There is only the American version of the original drug available abroad, and the price is as high as more than 70,000 yuan.